BMX-001 + Paclitaxel in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer

Clinical trial NCT06620029 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06620029
Sponsor: BioMimetix JV, LLC
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Endometrial Cancer, Endometrial Neoplasm

Start date: 2025-04-01
Primary completion: 2027-03-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.